Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 558
Filtrar
1.
Yakugaku Zasshi ; 142(1): 17-25, 2022.
Artículo en Japonés | MEDLINE | ID: mdl-34980747

RESUMEN

To understand fungal contamination in the indoor environments of the disaster region, surveys were conducted to detect mycoflora in temporary shelters, prefabricated temporary housing, private housing, and rented apartments in areas affected by the Great East Japan Earthquake. The results from the surveys of temporary shelters indicated that the indoor-air fungal counts at all sampling points were less than 1000 colony forming units (cfu)/m3, which is the recommended limit for fungal contamination in indoor air. However, the Aspergillus counts were high compared to the indoor environments of typical housing. Since Aspergillus is a known allergenic genus, careful attention should be paid to residents' health. The results of the surveys of private housing and rented apartments also indicated that fungal counts were highest during the rainy season throughout the summer. In contrast, temporary housing had a maximum fungal count in the winter. The extremely high level of fungal condensation in indoor air may have been due to the high relative humidity and loss of heat insulation in the buildings' attics. It is thought that these problems happen most commonly in colder regions, such as the entire area affected by the Great East Japan Earthquake. The case of a patient with allergic bronchopulmonary mycosis caused by a large amount of Eurotium herbariorum mold in his temporary housing was reported to demonstrate the health risks posed by fungi in this disaster region.


Asunto(s)
Contaminación del Aire Interior/análisis , Aspergillus , Terremotos , Inundaciones , Hongos , Vivienda , Aspergilosis Pulmonar Invasiva/microbiología , Aspergillus/patogenicidad , Frío , Recuento de Colonia Microbiana , Humedad , Aspergilosis Pulmonar Invasiva/epidemiología , Japón , Riesgo , Estaciones del Año
2.
Molecules ; 26(23)2021 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-34885770

RESUMEN

Epilobium angustifolium L. is a popular medicinal plant found in many regions of the world. This plant contains small amounts of essential oil whose composition and properties have not been extensively investigated. There are few reports in the literature on the antioxidant and antifungal properties of this essential oil and the possibility of applying it as a potential promoter of the skin penetration of drugs. The essential oil was obtained by distillation using a Clavenger type apparatus. The chemical composition was analyzed by the GC-MS method. The major active compounds of E. angustifolium L. essential oil (EOEa) were terpenes, including α-caryophyllene oxide, eucalyptol, ß-linalool, camphor, (S)-carvone, and ß-caryophyllene. The analyzed essential oil was also characterized by antioxidant activity amounting to 78% RSA (Radical Scavenging Activity). Antifungal activity against the strains Aspergillus niger, A. ochraceus, A. parasiticum, and Penicillium cyclopium was also determined. The largest inhibition zone was observed for strains from the Aspergillus group. The EOEa enhanced the percutaneous penetration of ibuprofen and lidocaine. After a 24 h test, the content of terpene in the skin and the acceptor fluid was examined. It has been shown that the main compounds contained in the essential oil do not penetrate through the skin, but accumulate in it. Additionally, FTIR-ATR analysis showed a disturbance of the stratum corneum (SC) lipids caused by the essential oil application. Due to its rich composition and high biological activity, EOEa may be a potential candidate to be applied, for example, in the pharmaceutical or cosmetic industries. Moreover, due to the reaction of the essential oil components with SC lipids, the EOEa could be an effective permeation enhancer of topically applied hydrophilic and lipophilic drugs.


Asunto(s)
Epilobium/química , Micosis/tratamiento farmacológico , Aceites Volátiles/química , Extractos Vegetales/química , Antifúngicos/química , Antifúngicos/farmacología , Antioxidantes/química , Antioxidantes/farmacología , Aspergillus/efectos de los fármacos , Aspergillus/patogenicidad , Cromatografía de Gases y Espectrometría de Masas , Humanos , Micosis/microbiología , Aceites Volátiles/farmacología , Penicillium/efectos de los fármacos , Penicillium/patogenicidad , Extractos Vegetales/farmacología , Plantas Medicinales/química , Piel/efectos de los fármacos , Absorción Cutánea/efectos de los fármacos , Terpenos/química , Terpenos/farmacología
3.
PLoS One ; 16(10): e0259302, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34714880

RESUMEN

Fungal infection and synthesis of mycotoxins in coffee leads to significant economic losses. This study aimed to investigate the prevalence of toxigenic fungi, their metabolites, and the effect of traditional roasting and brewing on ochratoxin A (OTA) and aflatoxins (AFs) contents of naturally contaminated coffee samples. In addition, in vivo biocontrol assays were performed to explore the antagonistic activities of Bacillus simplex 350-3 (BS350-3) on the growth and mycotoxins synthesis of Aspergillus ochraceus and A. flavus. The relative density of A. niger, A. flavus, Penicillium verrucosum and A. carbonarius on green coffee bean was 60.82%, 7.21%, 3.09% and 1.03%, respectively. OTA contents were lowest in green coffee beans (2.15 µg/kg), followed by roasted (2.76 µg/kg) and soluble coffee (8.95 µg/kg). Likewise, AFs levels were highest in soluble coffee (90.58 µg/kg) followed by roasted (33.61 µg/kg) and green coffee (9.07 µg/kg). Roasting naturally contaminated coffee beans at three traditional methods; low, medium and high, followed by brewing resulted in reduction of 58.74% (3.50 µg/kg), 60.88% (3.72 µg/kg) and 64.70% (4.11 µg/kg) in OTA and 40.18% (34.65 µg/kg), 47.86% (41.17 µg/kg) and 62.38% (53.73 µg/kg) AFs contents, respectively. Significant inhibitions of AFs and OTA synthesis by A. flavus and A. carbonarius, respectively, on infected coffee beans were observed in presence of Bacillus simplex BS350-3 volatiles. Gas chromatography mass spectrochemistry (GC-MS/MS) analysis of head-space BS350-3 volatiles showed quinoline, benzenemethanamine and 1-Octadecene as bioactive antifungal molecules. These findings suggest that marketed coffee samples are generally contaminated with OTA and AFs, with a significant level of roasted and soluble coffee contaminated above EU permissible limits for OTA. Further, along with coffee roasting and brewing; microbial volatiles can be optimized to minimize the dietary exposure to mycotoxins.


Asunto(s)
Coffea/microbiología , Microbiota , Alquenos/metabolismo , Aspergillus/metabolismo , Aspergillus/patogenicidad , Bacillus/metabolismo , Bacillus/patogenicidad , Bencilaminas/metabolismo , Coffea/metabolismo , Micotoxinas/metabolismo , Penicillium/metabolismo , Penicillium/patogenicidad , Quinolinas/metabolismo , Semillas/microbiología
4.
Int J Mol Sci ; 22(11)2021 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-34205910

RESUMEN

To overcome the limitations of the Limulus amebocyte lysate (LAL) assay method for the diagnosis of invasive fungal infection, we applied a reaction system combining recombinant ß-glucan binding proteins and a scanning single-molecule counting (SSMC) method. A novel (1→3)-ß-D-glucan recognition protein (S-BGRP) and a (1→6)-ß-glucanase mutant protein were prepared and tested for the binding of (1→6)-branched (1→3)-ß-D-glucan from fungi. S-BGRP and (1→6)-ß-glucanase mutant proteins reacted with ß-glucan from Candida and Aspergillus spp. Although LAL cross-reacted with plant-derived ß-glucans, the new detection system using the SSMC method showed low sensitivity to plant (1→3)-ß-D-glucan, which significantly improved the appearance of false positives, a recognized problem with the LAL method. Measurement of ß-glucan levels by the SSMC method using recombinant ß-glucan-binding proteins may be useful for the diagnosis of fungal infections. This study shows that this detection system could be a new alternative diagnostic method to the LAL method.


Asunto(s)
Técnicas Biosensibles , Endotoxinas/aislamiento & purificación , Micosis/diagnóstico , beta-Glucanos/aislamiento & purificación , Aspergillus/química , Aspergillus/aislamiento & purificación , Aspergillus/patogenicidad , Candida/química , Candida/aislamiento & purificación , Candida/patogenicidad , Endotoxinas/química , Humanos , Micosis/microbiología , Imagen Individual de Molécula , beta-Glucanos/química
5.
Respir Med ; 185: 106492, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34139578

RESUMEN

Fungal pneumonia is a dreaded complication encountered after kidney transplantation, complicated by increased mortality and often associated with graft failure. Diagnosis can be challenging because the clinical presentation is non-specific and diagnostic tools have limited sensitivity and specificity in kidney transplant recipients and must be interpreted in the context of the clinical setting. Management is difficult due to the increased risk of dissemination and severity, multiple comorbidities, drug interactions and reduced immunosuppression which should be applied as an important adjunct to therapy. This review will focus on the main causes of fungal pneumonia in kidney transplant recipients including Pneumocystis, Aspergillus, Cryptococcus, mucormycetes and Histoplasma. Epidemiology, clinical presentation, laboratory and radiographic features, specific characteristics will be discussed with an update on diagnostic procedures and treatment.


Asunto(s)
Aspergillus/patogenicidad , Cryptococcus/patogenicidad , Histoplasma/patogenicidad , Trasplante de Riñón/efectos adversos , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/microbiología , Mucorales/patogenicidad , Pneumocystis/patogenicidad , Neumonía/diagnóstico , Neumonía/microbiología , Antifúngicos/administración & dosificación , Antifúngicos/efectos adversos , Interacciones Farmacológicas , Femenino , Humanos , Huésped Inmunocomprometido , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/epidemiología , Masculino , Neumonía/tratamiento farmacológico , Neumonía/epidemiología
6.
Genetics ; 218(2)2021 06 24.
Artículo en Inglés | MEDLINE | ID: mdl-33944921

RESUMEN

Aspergillosis is an important opportunistic human disease caused by filamentous fungi in the genus Aspergillus. Roughly 70% of infections are caused by Aspergillus fumigatus, with the rest stemming from approximately a dozen other Aspergillus species. Several of these pathogens are closely related to A. fumigatus and belong in the same taxonomic section, section Fumigati. Pathogenic species are frequently most closely related to nonpathogenic ones, suggesting Aspergillus pathogenicity evolved multiple times independently. To understand the repeated evolution of Aspergillus pathogenicity, we performed comparative genomic analyses on 18 strains from 13 species, including 8 species in section Fumigati, which aimed to identify genes, both ones previously connected to virulence as well as ones never before implicated, whose evolution differs between pathogens and nonpathogens. We found that most genes were present in all species, including approximately half of those previously connected to virulence, but a few genes were section- or species-specific. Evolutionary rate analyses identified over 1700 genes whose evolutionary rate differed between pathogens and nonpathogens and dozens of genes whose rates differed between specific pathogens and the rest of the taxa. Functional testing of deletion mutants of 17 transcription factor-encoding genes whose evolution differed between pathogens and nonpathogens identified eight genes that affect either fungal survival in a model of phagocytic killing, host survival in an animal model of fungal disease, or both. These results suggest that the evolution of pathogenicity in Aspergillus involved both conserved and species-specific genetic elements, illustrating how an evolutionary genomic approach informs the study of fungal disease.


Asunto(s)
Aspergilosis/microbiología , Aspergillus/patogenicidad , Proteínas Fúngicas/genética , Factores de Virulencia/genética , Amebozoos/microbiología , Animales , Aspergillus/genética , Modelos Animales de Enfermedad , Evolución Molecular , Regulación Fúngica de la Expresión Génica , Genoma Fúngico , Genómica , Humanos , Mariposas Nocturnas/microbiología , Filogenia , Especificidad de la Especie , Factores de Transcripción/genética
8.
Int J Mol Sci ; 22(9)2021 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-33926042

RESUMEN

The control of the fungal contamination on crops is considered a priority by the sanitary authorities of an increasing number of countries, and this is also due to the fact that the geographic areas interested in mycotoxin outbreaks are widening. Among the different pre- and post-harvest strategies that may be applied to prevent fungal and/or aflatoxin contamination, fungicides still play a prominent role; however, despite of countless efforts, to date the problem of food and feed contamination remains unsolved, since the essential factors that affect aflatoxins production are various and hardly to handle as a whole. In this scenario, the exploitation of bioactive natural sources to obtain new agents presenting novel mechanisms of action may represent a successful strategy to minimize, at the same time, aflatoxin contamination and the use of toxic pesticides. The Aflatox® Project was aimed at the development of new-generation inhibitors of aflatoxigenic Aspergillus spp. proliferation and toxin production, through the modification of naturally occurring molecules: a panel of 177 compounds, belonging to the thiosemicarbazones class, have been synthesized and screened for their antifungal and anti-aflatoxigenic potential. The most effective compounds, selected as the best candidates as aflatoxin containment agents, were also evaluated in terms of cytotoxicity, genotoxicity and epi-genotoxicity to exclude potential harmful effect on the human health, the plants on which fungi grow and the whole ecosystem.


Asunto(s)
Aflatoxinas/química , Aflatoxinas/aislamiento & purificación , Aspergillus flavus/química , Aflatoxinas/toxicidad , Antifúngicos/farmacología , Aspergillus/metabolismo , Aspergillus/patogenicidad , Aspergillus flavus/aislamiento & purificación , Aspergillus flavus/metabolismo , Aspergillus flavus/patogenicidad , Productos Agrícolas/microbiología , Ecosistema , Contaminación de Alimentos/prevención & control , Hongos/efectos de los fármacos , Fungicidas Industriales/farmacología , Humanos , Micotoxinas/toxicidad , Tiosemicarbazonas/química
9.
Intern Emerg Med ; 16(6): 1619-1627, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33751395

RESUMEN

Blot and colleagues have proposed putative invasive pulmonary aspergillosis (PIPA) definitions for troublesome diagnosis in suspected patients outside the classical criteria of immunosuppression. We retrospectively included in the study all admitted patients with an Aspergillus spp. positive culture within lower airway samples. Overall, Aspergillus spp. positivity in respiratory samples was 0.97 every 1000 hospital admissions (HA): 4.94 and 0.28/1000/HA, respectively, in intensive care units (ICUs) and medical wards (MW). 66.6% fulfilled PIPA criteria, and 33.4% were defined as colonized. 69.2% of PIPA diagnosis occurred in the ICU. Antifungal therapy was appropriate in 88.5% of subjects with PIPA and 37.5% of colonized, confirming the comparison between deads and lives. Patients with PIPA in the ICUs had more frequent COPD, sepsis or septic shock, acute kidney injury (AKI), needed more surgery, mechanical ventilation (MV), vasopressors, hemodialysis, blood or platelets transfusions. PIPA in MW had associated with a history of smoking, interstitial lung disease and inhaled steroid therapy. Overall mortality within 21 days was 50%: 54.2% in ICU, 36,8% in MW. Factors associated with death were length of hospitalization, influenza, pneumonia, liver transplant, AKI, ARDS, sepsis and septic shock. PIPA in the ICU had higher disease severity and needed more organ support than MW cases, despite that cases of PIPA in MW are emerging with trends difficult to demonstrate given the problematic diagnosis.


Asunto(s)
Aspergilosis Pulmonar Invasiva/diagnóstico , Anciano , Aspergilosis/diagnóstico , Aspergilosis/epidemiología , Aspergillus/efectos de los fármacos , Aspergillus/patogenicidad , Aspergillus flavus/efectos de los fármacos , Aspergillus flavus/patogenicidad , Aspergillus niger/efectos de los fármacos , Aspergillus niger/patogenicidad , Femenino , Humanos , Unidades de Cuidados Intensivos/organización & administración , Unidades de Cuidados Intensivos/estadística & datos numéricos , Aspergilosis Pulmonar Invasiva/epidemiología , Italia/epidemiología , Masculino , Persona de Mediana Edad , Habitaciones de Pacientes/organización & administración , Habitaciones de Pacientes/estadística & datos numéricos , Estudios Retrospectivos , Factores de Riesgo , Estadísticas no Paramétricas
10.
Sci Rep ; 11(1): 3777, 2021 02 12.
Artículo en Inglés | MEDLINE | ID: mdl-33580189

RESUMEN

Mycobacterium ulcerans secrete a series of non-ribosomal-encoded toxins known as mycolactones that are responsible for causing a disabling ulceration of the skin and subcutaneous tissues named Buruli ulcer. The disease is the sole non-contagion among the three most common mycobacterial diseases in humans. Direct contact with contaminated wetlands is a risk factor for Buruli ulcer, responsible for M. ulcerans skin carriage before transcutaneous inoculation with this opportunistic pathogen. In this study, we analysed the bacterial and fungal skin microbiota in individuals exposed to M. ulcerans in Burkina Faso. We showed that M. ulcerans-specific DNA sequences were detected on the unbreached skin of 6/52 (11.5%) asymptomatic farmers living in Sindou versus 0/52 (0%) of those living in the non-endemic region of Tenkodogo. Then, we cultured the skin microbiota of asymptomatic M. ulcerans carriers and negative control individuals, all living in the region of Sindou. A total of 84 different bacterial and fungal species were isolated, 21 from M. ulcerans-negative skin samples, 31 from M. ulcerans-positive samples and 32 from both. More specifically, Actinobacteria, Aspergillus niger and Aspergillus flavus were significantly associated with M. ulcerans skin carriage. We further observed that in vitro, mycolactones induced spore germination of A. flavus, attracting the fungal network. These unprecedented observations suggest that interactions with fungi may modulate the outcome of M. ulcerans skin carriage, opening new venues to the understanding of Buruli ulcer pathology, prophylaxis and treatment of this still neglected tropical infection.


Asunto(s)
Aspergilosis/epidemiología , Úlcera de Buruli/epidemiología , Piel/microbiología , Aspergillus/genética , Aspergillus/patogenicidad , Burkina Faso/epidemiología , Úlcera de Buruli/microbiología , ADN Bacteriano/genética , Hongos/genética , Humanos , Microbiota/genética , Mycobacterium ulcerans/patogenicidad , Piel/metabolismo
11.
Toxins (Basel) ; 13(2)2021 02 02.
Artículo en Inglés | MEDLINE | ID: mdl-33540740

RESUMEN

Aspergillus carbonarius is the principal fungal species responsible for ochratoxin A (OTA) contamination of grapes and derived products in the main viticultural regions worldwide. In recent years, co-expressed genes representing a putative-OTA gene cluster were identified, and the deletion of a few of them allowed the partial elucidation of the biosynthetic pathway in the fungus. In the putative OTA-gene cluster is additionally present a bZIP transcription factor (AcOTAbZIP), and with this work, A. carbonarius ΔAcOTAbZIP strains were generated to study its functional role. According to phylogenetic analysis, the gene is conserved in the OTA-producing fungi. A Saccharomyces cerevisiae transcription factor binding motif (TFBM) homolog, associated with bZIP transcription factors was present in the A. carbonarius OTA-gene cluster no-coding regions. AcOTAbZIP deletion results in the loss of OTA and the intermediates OTB and OTß. Additionally, in ΔAcOTAbZIP strains, a down-regulation of AcOTApks, AcOTAnrps, AcOTAp450, and AcOTAhal genes was observed compared to wild type (WT). These results provide evidence of the direct involvement of the AcOTAbZIP gene in the OTA biosynthetic pathway by regulating the involved genes. The loss of OTA biosynthesis ability does not affect fungal development as demonstrated by the comparison of ΔAcOTAbZIP strains and WT strains in terms of vegetative growth and asexual sporulation on three different media. Finally, no statistically significant differences in virulence were observed among ΔAcOTAbZIP strains and WT strains on artificially inoculated grape berries, demonstrating that OTA is not required by A. carbonarius for the pathogenicity process.


Asunto(s)
Aspergillus/metabolismo , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/metabolismo , Ocratoxinas/biosíntesis , Aspergillus/genética , Aspergillus/crecimiento & desarrollo , Aspergillus/patogenicidad , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/genética , Frutas/microbiología , Eliminación de Gen , Regulación Fúngica de la Expresión Génica , Familia de Multigenes , Mutación , Reproducción Asexuada , Metabolismo Secundario , Factores de Tiempo , Virulencia , Vitis/microbiología
12.
Am J Trop Med Hyg ; 104(3): 871-873, 2021 01 04.
Artículo en Inglés | MEDLINE | ID: mdl-33399044

RESUMEN

Mycetoma is an infrequent subcutaneous infection caused by true fungi (eumycetoma) or aerobic actinomycetes (actinomycetoma). We report the case of a 62-year-old man with eumycetoma involving the left foot and ankle. Skin biopsy revealed black-brown grains, and in culture, a white colony fungus grew at day 8. Molecular sequencing using ITS1-ITS4 primers identified the species as Aspergillus sydowii. The patient was treated with itraconazole 200 mg twice daily and terbinafine 250 mg daily for 8 months, with complete response and no recurrence after 2.5 years of follow-up. Aspergillus sydowii is a saprotrophic fungus that rarely causes skin or nail disease. No cases of eumycetoma caused by this agent have been previously reported. As its geographic distribution continues to expand, it may increasingly be recognized as a cause of human disease.


Asunto(s)
Tobillo/fisiopatología , Aspergillus/patogenicidad , Pie/fisiopatología , Itraconazol/uso terapéutico , Micetoma/diagnóstico , Micetoma/tratamiento farmacológico , Micetoma/fisiopatología , Terbinafina/uso terapéutico , Tobillo/microbiología , Antifúngicos/uso terapéutico , Femenino , Pie/microbiología , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
13.
Mol Plant Pathol ; 22(1): 117-129, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33169928

RESUMEN

Aspergillus carbonarius is the major producer of ochratoxin A (OTA) among Aspergillus species, but the contribution of this secondary metabolite to fungal virulence has not been assessed. We characterized the functions and addressed the roles of three factors in the regulation of OTA synthesis and pathogenicity in A. carbonarius: LaeA, a transcriptional factor regulating the production of secondary metabolites; polyketide synthase, required for OTA biosynthesis; and glucose oxidase (GOX), regulating gluconic acid (GLA) accumulation and acidification of the host tissue during fungal growth. Deletion of laeA in A. carbonarius resulted in significantly reduced OTA production in colonized nectarines and grapes. The ∆laeA mutant was unable to efficiently acidify the colonized tissue, as a direct result of diminished GLA production, leading to attenuated virulence in infected fruit compared to the wild type (WT). The designed Acpks-knockout mutant resulted in complete inhibition of OTA production in vitro and in colonized fruit. Interestingly, physiological analysis revealed that the colonization pattern of the ∆Acpks mutant was similar to that of the WT strain, with high production of GLA in the colonized tissue, suggesting that OTA accumulation does not contribute to A. carbonarius pathogenicity. Disruption of the Acgox gene inactivated GLA production in A. carbonarius, and this mutant showed attenuated virulence in infected fruit compared to the WT strain. These data identify the global regulator LaeA and GOX as critical factors modulating A. carbonarius pathogenicity by controlling transcription of genes important for fungal secondary metabolism and infection.


Asunto(s)
Aspergillus/enzimología , Proteínas Fúngicas/metabolismo , Ocratoxinas/metabolismo , Enfermedades de las Plantas/microbiología , Prunus persica/microbiología , Vitis/microbiología , Aspergillus/genética , Aspergillus/metabolismo , Aspergillus/patogenicidad , Frutas/microbiología , Proteínas Fúngicas/genética , Glucosa Oxidasa/genética , Glucosa Oxidasa/metabolismo , Mutación , Sintasas Poliquetidas/genética , Sintasas Poliquetidas/metabolismo , Virulencia
15.
BMC Microbiol ; 20(1): 342, 2020 11 11.
Artículo en Inglés | MEDLINE | ID: mdl-33176679

RESUMEN

BACKGROUND: Members of the genus Aspergillus display a variety of lifestyles, ranging from saprobic to pathogenic on plants and/or animals. Increased genome sequencing of economically important members of the genus permits effective use of "-omics" comparisons between closely related species and strains to identify candidate genes that may contribute to phenotypes of interest, especially relating to pathogenicity. Protein-coding genes were predicted from 216 genomes of 12 Aspergillus species, and the frequencies of various structural aspects (exon count and length, intron count and length, GC content, and codon usage) and functional annotations (InterPro, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes terms) were compared. RESULTS: Using principal component analyses, the three sets of functional annotations for each strain were clustered by species. The species clusters appeared to separate by pathogenicity on plants along the first dimensions, which accounted for over 20% of the variance. More annotations for genes encoding pectinases and secondary metabolite biosynthetic enzymes were assigned to phytopathogenic strains from species such as Aspergillus flavus. In contrast, Aspergillus fumigatus strains, which are pathogenic to animals but not plants, were assigned relatively more terms related to phosphate transferases, and carbohydrate and amino-sugar metabolism. Analyses of publicly available RNA-Seq data indicated that one A. fumigatus protein among 17 amino-sugar processing candidates, a hexokinase, was up-regulated during co-culturing with human immune system cells. CONCLUSION: Genes encoding hexokinases and other proteins of interest may be subject to future manipulations to further refine understanding of Aspergillus pathogenicity factors.


Asunto(s)
Aspergillus/genética , Factores de Virulencia/genética , Animales , Aspergillus/clasificación , Aspergillus/patogenicidad , Genes Fúngicos/genética , Genoma Fúngico/genética , Hexoquinasa/genética , Humanos , Anotación de Secuencia Molecular , Enfermedades de las Plantas/microbiología
16.
PLoS One ; 15(11): e0242862, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33232384

RESUMEN

Bunch rot in grapes is an aggressive disease and needs to be controlled during the postharvest period. We investigate the antifungal potential of Zanthoxylum bungeanum Maxim., Zanthoxylum rhetsa, Cuminum cyminum, Coriandrum sativum, and Zingiber montanum (J. Koenig) Link ex A. Dietr. essential oils against Aspergillus aculeatus that cause bunch rot disease on postharvest grapes. C. cyminum essential oil exhibited stronger significantly inhibition percentage of 95.08% than other treatments in in vitro assay. Cumin aldehyde (33.94%) and α-terpinen-7-al (32.20%) were identified as major volatile compounds in C. cyminum oil. Antifungal potential of C. cyminum oil was then tested in conidia germination and in vitro tests compared to cumin aldehyde and α-terpinen-7-al. Their EC50 values against the conidial germination were also estimated. Significant reduction of conidia germination was also detected in C. cyminum essential oil and cumin aldehyde at a concentration of 1,000 and 100 µg/mL, respectively. EC50 values of the C. cyminum essential oil, cumin aldehyde, and α-terpinen-7-al were 67.28 µg/mL, 9.31 µg/mL, and 13.23 µg/mL, respectively. In vivo assay, the decrease of the disease severity (0.69%) and incidence (1.48%) percentage of A. aculeatus on grape berries treated at 1,000 µg/mL of C. cyminum essential oil was significantly greater than that obtained from other treatments after 10 days incubation. In addition, grape berries treated with C. cyminum essential oil decreased weight loss and retained fruit firmness. The changing of total soluble solids, total phenolic content, and antioxidant activity are also delayed in treated fruits. Therefore, essential oil of C. cyminum may be applied as a biological antifungal agent to control A. aculeatus in postharvest grapes without any negative effects on its quality.


Asunto(s)
Cuminum/química , Aceites Volátiles/farmacología , Enfermedades de las Plantas/prevención & control , Vitis/efectos de los fármacos , Antifúngicos/química , Antifúngicos/farmacología , Aspergillus/efectos de los fármacos , Aspergillus/patogenicidad , Humanos , Aceites Volátiles/química , Enfermedades de las Plantas/microbiología , Vitis/crecimiento & desarrollo , Vitis/microbiología
17.
Genes (Basel) ; 11(11)2020 11 09.
Artículo en Inglés | MEDLINE | ID: mdl-33182427

RESUMEN

Candida, Aspergillus, and Cryptococcus species are the most frequent cause of severe human fungal infections. Clinically relevant antifungal drugs are scarce, and their effectiveness are hampered by the ability of fungal cells to develop drug resistance mechanisms. Drug effectiveness and drug resistance in human pathogens is very often affected by their "transportome". Many studies have covered a panoply of drug resistance mechanisms that depend on drug efflux pumps belonging to the ATP-Binding Cassette and Major Facilitator Superfamily. However, the study of drug uptake mechanisms has been, to some extent, overlooked in pathogenic fungi. This review focuses on discussing current knowledge on drug uptake systems in fungal pathogens, highlighting the need for further studies on this topic of great importance. The following subjects are covered: (i) drugs imported by known transporter(s) in pathogenic fungi; and (ii) drugs imported by known transporter(s) in the model yeast Saccharomyces cerevisiae or in human parasites, aimed at the identification of their homologs in pathogenic fungi. Besides its contribution to increase the understanding of drug-pathogen interactions, the practical implications of identifying drug importers in human pathogens are discussed, particularly focusing on drug development strategies.


Asunto(s)
Portadores de Fármacos/uso terapéutico , Farmacorresistencia Fúngica/efectos de los fármacos , Hongos/patogenicidad , Transportadoras de Casetes de Unión a ATP/metabolismo , Antifúngicos/farmacología , Aspergillus/metabolismo , Aspergillus/patogenicidad , Transporte Biológico , Candida albicans/metabolismo , Candida albicans/patogenicidad , Portadores de Fármacos/metabolismo , Hongos/metabolismo , Proteínas de Transporte de Membrana , Micosis/tratamiento farmacológico , Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/patogenicidad
18.
Med Mycol J ; 61(3): 49-53, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32863328

RESUMEN

BACKGROUND: Cerebral aspergillosis usually affects immunocompromised hosts and may rarely occur in immunocompetent individuals. Due to its angio-invasive nature, Aspergillus may cause various vascular complications, particularly mycotic aneurysms and infarcts. CASE PRESENTATION: A 22-year-old immunocompetent male with diagnosed case of sino-cerebral aspergillosis was taking voriconazole for two months. His headache worsened and repeat imaging showed an increase in the size of the lesion. The patient was managed with right frontal craniotomy and surgical debridement, and voriconazole was continued. After ten days of uneventful post-operative course, the patient developed left-sided hemispheric infarct. The patient is doing well at nine months' follow-up, and he is off voriconazole for three months after the follow-up imaging showed complete resolution of disease. CONCLUSION: Treatment of choice for cerebral aspergillosis is voriconazole. Surgical debridement may be a useful adjunct in patients not responding to voriconazole alone.


Asunto(s)
Aspergilosis/complicaciones , Aspergilosis/terapia , Aspergillus/patogenicidad , Infecciones Fúngicas del Sistema Nervioso Central/complicaciones , Infecciones Fúngicas del Sistema Nervioso Central/terapia , Infarto Cerebral/etiología , Inmunocompetencia , Adulto , Craneotomía , Desbridamiento , Estudios de Seguimiento , Humanos , Masculino , Voriconazol/administración & dosificación , Adulto Joven
19.
Mycoses ; 63(10): 1021-1032, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32744334

RESUMEN

The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs. Although this strategy has resulted in an overall reduction in IFIs, a subset of patients develop breakthrough IFIs with substantial morbidity and mortality in this population. Here, we review the most significant risk factors for breakthrough IFIs in haematology patients, solid organ transplant recipients, and patients in the intensive care unit, focusing particularly on host factors, and highlight areas that require future investigation.


Asunto(s)
Infecciones Fúngicas Invasoras , Corticoesteroides/efectos adversos , Antifúngicos/uso terapéutico , Aspergillus/aislamiento & purificación , Aspergillus/patogenicidad , Candida/aislamiento & purificación , Candida/patogenicidad , Catéteres Venosos Centrales/efectos adversos , Catéteres Venosos Centrales/microbiología , Equinocandinas/uso terapéutico , Fluconazol/uso terapéutico , Fusarium/aislamiento & purificación , Fusarium/patogenicidad , Predisposición Genética a la Enfermedad , Neoplasias Hematológicas/complicaciones , Humanos , Huésped Inmunocomprometido , Unidades de Cuidados Intensivos , Infecciones Fúngicas Invasoras/diagnóstico , Infecciones Fúngicas Invasoras/tratamiento farmacológico , Infecciones Fúngicas Invasoras/epidemiología , Infecciones Fúngicas Invasoras/prevención & control , Mucorales/aislamiento & purificación , Mucorales/patogenicidad , Micosis/diagnóstico , Micosis/tratamiento farmacológico , Micosis/epidemiología , Micosis/prevención & control , Neutropenia/complicaciones , Infecciones Oportunistas/tratamiento farmacológico , Infecciones Oportunistas/epidemiología , Infecciones Oportunistas/microbiología , Infecciones Oportunistas/prevención & control , Trasplante de Órganos/efectos adversos , Penicillium/aislamiento & purificación , Penicillium/patogenicidad , Factores de Riesgo , Triazoles/uso terapéutico
20.
Genetics ; 216(2): 481-497, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32817009

RESUMEN

Aspergillus fumigatus is a major human pathogen. In contrast, Aspergillus fischeri and the recently described Aspergillus oerlinghausenensis, the two species most closely related to A. fumigatus, are not known to be pathogenic. Some of the genetic determinants of virulence (or "cards of virulence") that A. fumigatus possesses are secondary metabolites that impair the host immune system, protect from host immune cell attacks, or acquire key nutrients. To examine whether secondary metabolism-associated cards of virulence vary between these species, we conducted extensive genomic and secondary metabolite profiling analyses of multiple A. fumigatus, one A. oerlinghausenensis, and multiple A. fischeri strains. We identified two cards of virulence (gliotoxin and fumitremorgin) shared by all three species and three cards of virulence (trypacidin, pseurotin, and fumagillin) that are variable. For example, we found that all species and strains examined biosynthesized gliotoxin, which is known to contribute to virulence, consistent with the conservation of the gliotoxin biosynthetic gene cluster (BGC) across genomes. For other secondary metabolites, such as fumitremorgin, a modulator of host biology, we found that all species produced the metabolite but that there was strain heterogeneity in its production within species. Finally, species differed in their biosynthesis of fumagillin and pseurotin, both contributors to host tissue damage during invasive aspergillosis. A. fumigatus biosynthesized fumagillin and pseurotin, while A. oerlinghausenensis biosynthesized fumagillin and A. fischeri biosynthesized neither. These biochemical differences were reflected in sequence divergence of the intertwined fumagillin/pseurotin BGCs across genomes. These results delineate the similarities and differences in secondary metabolism-associated cards of virulence between a major fungal pathogen and its nonpathogenic closest relatives, shedding light onto the genetic and phenotypic changes associated with the evolution of fungal pathogenicity.


Asunto(s)
Aspergillus/genética , Genes Fúngicos , Variación Genética , Micotoxinas/genética , Metabolismo Secundario , Aspergillus/clasificación , Aspergillus/metabolismo , Aspergillus/patogenicidad , Familia de Multigenes , Micotoxinas/biosíntesis , Filogenia , Virulencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...